Login
$UROY
$3.40 -$0.03 (0.87%) Close

Interim Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jul 31, 2026
Q4 FY2026
As of Apr 30, 2026
Assets
Current Assets
Cash
Restricted cash
Accounts receivable
Investments in equity securities
Inventories
Prepaids and other receivables
Total current assets
Non-current Assets
Right-of-use assets
Royalties
Land
Mineral properties and interests, net
Deferred tax assets
Other long-term assets
Total non-current Assets
Total Assets
Liabilities
Current Liabilities
Accounts payable and accrued liabilities
Other payables
Advanced minimum royalties
Deferred revenue
Current portion of lease liability
Short-term loan
Subscription receipts liability
Long-term debt - current
Income tax payable
Total Current Liabilities
Non-current Liabilities
Mandatorily redeemable preferred stock
Non-current portion of lease liability
Long-term debt
Other long-term liabilities
Deferred income tax liability
Total Non-current Liabilities
Total Liabilities
Stockholders' Equity
Common stock, $0.001 par value, 999,990,000 shares authorized, 377,210,623 shares issued and outstanding (April 30, 2026: no par value)
Exchangeable shares, no par value, 3,856,695 shares issued and outstanding (April 30, 2026: nil)
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total Stockholders' Equity
Non-controlling interest
Total Equity, including Non-controlling Interest
Total Liabilities and Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support